Project Grant R03DA060771

Award Date 6/15/24
Completion Date 5/31/26
Dollars Obligated $455K
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
MIDDLE CITY EAST, PA 19102, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $240,108 to Drexel University to elucidate the corticolimbic circuit and neuroimmune mechanisms underlying the dysregulation of reward-seeking behavior in the comorbid condition of HIV and cocaine use disorder (CUD). The research aims to use circuit-specific optogenetics and chemogenetics in mouse models to understand how HIV infection,...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $162,486 to The Medical College of Wisconsin, Inc. to study the effects of concurrent chronic stress and cocaine self-administration on medial prefrontal cortex (mPFC) microglia and drug choice behavior in a rat model. The key objectives are to: Use flow cytometry, qRT-PCR, and spine morphometry to investigate microglial activity profiles and...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $3,580,802 to Yale University to conduct research on stress-immune mechanisms in people living with HIV, cannabis use disorder, and depression. The key goals are to: Determine the hypothalamic-pituitary-adrenal (HPA) and immune response to acute stress among healthy controls, people living with HIV, and those with complex morbidity (HIV,...
The National Institute on Drug Abuse (NIDA) awarded a $1,381,500 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Nebraska Medical Center (UNMC) to explore sex differences in the establishment and maintenance of HIV/SIV reservoirs in the context of opioid use. The overarching goal is to delineate the role of sex factors in seeding and establishing viral reservoirs (Aim 1) and determine the location, abundance, and persistence of viral reservoirs...
This federal Project Grant award for $263,119 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) is focused on developing NLRP3 inhibitors to address HIV-associated neuroinflammation in cocaine use. The key objectives are to computationally design, synthesize, and screen novel analogues of a lead compound, AMS-17, to improve its biological activity and maintain low toxicity. The project involves in vitro and in vivo screening of...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $1,475,580 to The Regents of the University of California, San Francisco (UCSF) to conduct in-depth spatial characterization of HIV-host cellular interactions within the central nervous system (CNS) of people living with HIV (PWH) who died suddenly. The key objectives are to: (1) implement innovative spatial multi-omic assays to analyze the...
The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $1,372,480 Project Grant to the Board of Regents of the University of Nebraska's University of Nebraska Medical Center (UNMC). The grant supports a 5-year research study focused on elucidating the molecular mechanisms underlying the interplay between HIV transactivator of transcription (Tat) protein, cocaine, and combination antiretroviral therapy (cART) in activating the...
This Project Grant award of $2,312,085, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to investigate the molecular mechanisms linking HIV infection and opioid use disorder that contribute to neuroinflammation and HIV-associated neurocognitive disorders (HAND). The research, led by the Trustees of Boston University's Medical Campus, will utilize primary human iPSC-derived microglia cultures to...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $2,940,518 to Wake Forest University Health Sciences (WFUHS) to conduct a randomized controlled trial (RCT) investigating neuroimmune mechanisms linking psychosocial stress, stimulant use, and depression in people living with HIV (PWH). The study aims to (1) examine the impact of a positive affect intervention (ARTEMIS) on neural...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $2,223,769 to the University of California, San Diego (UCSD) to conduct research on the intertwined mechanisms of HIV and opioid use on mitochondrial-mediated inflammasome activation and neurotoxicity. The research aims to elucidate how the convergence of HIV infection and opioid use leads to more severe neurological consequences, including...

HIV EFFECTS ON ASTROCYTIC REGULATION OF STRESS-INDUCED COCAINE REINSTATEMENT - PROJECT SUMMARY HIV INFECTION IS COMMONLY CO-OCCURRING WITH DRUG USE. BOTH HIV INFECTION AND DRUG USE ARE ASSOCIATED WITH ADRENAL DYSFUNCTION AND HORMONAL DYSREGULATION, WHICH CAN DRIVE IMPAIRMENTS IN RESPONSE TO STRESS. STRESS IS A MAJOR FACTOR AFFECTING HIV DISEASE OUTCOMES AND SUSCEPTIBILITY TO RELAPSE, HOWEVER THERE IS A LACK OF UNDERSTANDING OF THE FACTORS THAT PROMOTE RELAPSE IN PEOPLE LIVING WITH HIV. RESPONSIVITY TO STRESS IS REGULATED BY THE GLUCOCORTICOID, CORTISOL. HIV CAN RESULT IN ENHANCED BASAL CORTISOL LEVELS, BUT REDUCED CORTISOL RESPONSES TO STRESS. IN CONTRAST, COCAINE DEPENDENCE IS ASSOCIATED WITH ENHANCED BASAL AND STRESS-INDUCED CORTISOL RESPONSES. HOWEVER, THE INTERACTION OF HIV INFECTION AND COCAINE USE ON CORTISOL LEVELS IS NOT WELL CHARACTERIZED. IN RODENT MODELS, COCAINE EXPOSURE ENHANCES THE CORTICOSTERONE RESPONSE TO STRESS IN MALE AND FEMALE RODENTS, WHILE TAT TRANSGENIC MALE, BUT NOT FEMALE, MICE EXHIBIT BLUNTED CORTICOSTERONE RESPONSES TO STRESS. THUS, HIV- INFECTED FEMALES MAY BE MORE VULNERABLE TO STRESS-INDUCED REINSTATEMENT OF COCAINE SEEKING DUE TO LACK OF BLUNTED CORTICOSTERONE RESPONSES BY TAT. GLUCOCORTICOID SIGNALING AT ASTROCYTES MAY BE AN IMPORTANT MEDIATOR OF THIS RESPONSE. THE GLUCOCORTICOID RECEPTOR CAN BE DOWNREGULATED IN RESPONSE TO STRESS, AND THIS EFFECT APPEARS TO BE SPECIFIC TO ASTROCYTES. ASTROCYTES ARE ALSO IMPORTANT MEDIATORS OF RELAPSE-RELATED BEHAVIORS AND ARE INDEPENDENTLY REGULATED BY COCAINE AND HIV INFECTION. FURTHER, MODULATION OF GLUCOCORTICOID RECEPTORS REGULATES ASTROCYTIC CALCIUM SIGNALING, SUGGESTING THAT STRESS MODULATES ASTROCYTIC ACTIVITY. OUR PRELIMINARY DATA INDICATE THAT STRESS-INDUCED REINSTATEMENT OF REWARD SEEKING IS ASSOCIATED WITH ENHANCED ASTROCYTIC CALCIUM SIGNALING IN THE REWARD-PAIRED CONTEXT. THUS, ASTROCYTIC GLUCOCORTICOID SIGNALING MAY BE A POTENTIAL REGULATOR OF THE STRESS RESPONSE AND STRESS-INDUCED RELAPSE-LIKE BEHAVIOR IN THE CONTEXT OF HIV INFECTION. AIM 1 WILL DETERMINE THE EFFECTS OF ECOHIV INOCULATION ON STRESS-INDUCED CORTICOSTERONE LEVELS AND ASTROCYTIC GLUCOCORTICOID RECEPTOR EXPRESSION FOLLOWING A HISTORY OF COCAINE EXPOSURE IN MALE AND FEMALE MICE. MALE AND FEMALE MICE WILL BE INOCULATED WITH ECOHIV AND UNDERGO COCAINE EXPOSURE AND WITHDRAWAL, AND THEN BE SUBJECTED TO FORCED SWIM STRESS. SERUM CORTICOSTERONE LEVELS AND IMMUNOFLUORESCENT LABELING OF ASTROCYTIC GR WILL BE ASSESSED TO DETERMINE IF FEMALE MICE EXHIBIT ENHANCED STRESS RESPONSES FOLLOWING ECOHIV INFECTION. AIM 2 WILL DETERMINE WHETHER ECOHIV INFECTION SEX-SPECIFICALLY PROMOTES STRESS-INDUCED REINSTATEMENT OF COCAINE SEEKING. MALE AND FEMALE MICE WILL BE INOCULATED WITH ECOHIV AND BE TRAINED IN A CONDITIONED PLACE PREFERENCE PARADIGM FOR COCAINE, FOLLOWED BY EXTINCTION AND REINSTATEMENT FOLLOWING FORCED SWIM STRESS EXPOSURE TO DETERMINE IF ECOHIV-INFECTED FEMALE MICE EXHIBIT ENHANCED STRESS-INDUCED REINSTATEMENT. THE RESULTS OF THESE EXPERIMENTS WILL IDENTIFY A POTENTIAL TARGET FOR REDUCING STRESS-INDUCED RELAPSE IN PEOPLE LIVING WITH HIV. FURTHER, WE WILL GAIN SIGNIFICANT KNOWLEDGE OF SEX- SPECIFIC REGULATION OF THE GLUCOCORTICOID SYSTEM BY ECOHIV INFECTION.

Posted 6/11/24, 12:00 AM